Why This Fund Trimmed Million of TPB Despite Sales Surge
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
Volatility of index funds for retirement can be managed through thoughtful allocation, rebalancing, and a long-term perspective.
23,516 articlesAs Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
The Invesco PDBC ETF jumped higher as crude oil rallied to the 98th percentile of its five-year range, highlighting t...
The IEA just revised demand down by 420,000 barrels per day, signaling slower consumption ahead. This shift could res...
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...
Floating-rate Treasuries have provided steadier income as rate volatility persists. This piece examines how USFR deli...
U.S. authorities target the Jalisco New Generation Cartel’s fuel networks, while investors watch how scott bessent go...
A new AI-driven forecast highlights two XRP price paths tied to a key CLARITY Act vote, with a possible surge to $5 o...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
Ready to start investing with $1,000 this February? This guide shows how to pick a balanced starter pack, use fractio...
Three ETFs are positioning investors for the next leg of AI-driven growth, offering diversified exposure as markets r...
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...